NEMESIS was created with the vision of identifying metabolism disrupting chemicals (MDCs) causing adverse metabolic effects and increasing mechanistic understanding of adverse metabolic effects of MDCs in liver, pancreas, and microbiota. Ultimately, the NEMESIS aims to develop novel effect biomarkers for metabolic disruptors, providing evidence on their health impacts. With a consortium of 14 partners […]